openPR Logo
Press release

Apheresis Market on Track to Hit USD 3.50 Billion by 2030, Growing at 7.82 Percentage CAGR

Apheresis Market

Apheresis Market

๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ CAGR is expected to be 7.82% during the forecast period and the market size is expected to reach nearly US$ 3.50 Bn. by 2030.

๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

The apheresis market is experiencing robust growth due to its vital role in therapeutic and donor blood collection procedures. Apheresis is a medical technology where blood is drawn from a donor or patient, separated into its components, and selectively retained or returned. This process is widely used in treating autoimmune diseases, blood disorders, and managing conditions like leukemia and multiple myeloma. The growing prevalence of chronic diseases, coupled with increasing demand for blood components like plasma, platelets, and red blood cells, is driving market expansion. Technological advancements in apheresis devices, including automated and portable systems, have enhanced efficiency and patient safety, further fueling market growth. Rising awareness of the importance of plasma donation and government initiatives supporting blood donation drives are additional factors contributing to the marketu2019s development. With increasing healthcare investments in emerging economies and a growing geriatric population prone to hematological conditions, the apheresis market is poised for significant advancements in the coming years.

๐†๐ž๐ญ ๐˜๐จ๐ฎ๐ซ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐ญ๐ก๐ž ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: https://www.maximizemarketresearch.com/request-sample/12723/

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

The apheresis market is driven by multiple factors, including the rising prevalence of chronic diseases and the increasing demand for plasma-derived therapies. The surge in autoimmune disorders, such as Guillain-Barru00e9 syndrome and myasthenia gravis, has heightened the demand for therapeutic apheresis procedures. Growing investments in healthcare infrastructure and R&D for advanced apheresis devices are fostering market growth. The demand for safe and efficient blood component separation techniques has led to the widespread adoption of automated apheresis systems. Additionally, the increasing awareness of the benefits of blood and plasma donation has boosted donor participation, particularly in developed regions. Government initiatives and supportive policies, such as funding for blood donation campaigns and reimbursement for apheresis procedures, are further driving the market. The need for efficient treatment options for hematological disorders and improved healthcare access in emerging economies also contribute significantly to the expansion of the apheresis market.

๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

Several trends are shaping the growth of the apheresis market. One of the key trends is the development of portable and user-friendly apheresis devices, enabling point-of-care treatments and expanding the scope of apheresis in homecare settings. The integration of artificial intelligence and machine learning in apheresis systems is enhancing efficiency, accuracy, and personalization of treatments. Another emerging trend is the increasing focus on donor safety, leading to innovations in disposable kits and real-time monitoring systems. The rise of therapeutic plasma exchange (TPE) for treating neurological and autoimmune disorders is gaining momentum, driven by improved outcomes and growing clinical adoption. Collaborations between healthcare providers and medical device manufacturers are fostering innovation, resulting in cost-effective and advanced solutions. Additionally, the push for sustainable and environmentally friendly practices in healthcare has prompted companies to develop energy-efficient apheresis machines. The expansion of plasma collection centers in emerging economies further highlights the global shift towards meeting the rising demand for plasma-derived therapies.

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐“๐จ๐๐š๐ฒ ๐Ÿ๐จ๐ซ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ: https://www.maximizemarketresearch.com/inquiry-before-buying/12723/

๐Œ๐ž๐ซ๐ ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐€๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐•๐ข๐ž๐ญ๐ง๐š๐ฆ: ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Vietnam's healthcare sector is experiencing a surge in demand for apheresis devices, driven by growing awareness of blood and plasma donation. Government initiatives to improve healthcare infrastructure are creating opportunities for local and international players. Companies like Haemonetics Corporation are actively collaborating with Vietnamese medical institutions to expand access to advanced apheresis solutions. With increasing investments in plasma collection centers, Vietnam is emerging as a key market in Southeast Asia.

๐“๐ก๐š๐ข๐ฅ๐š๐ง๐: ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Thailand's apheresis market is flourishing, supported by its robust healthcare system and rising medical tourism. The country has seen significant investments from global players such as Terumo BCT, who are introducing innovative apheresis technologies tailored for local needs. The adoption of therapeutic plasma exchange (TPE) for treating neurological and autoimmune disorders is on the rise, reflecting global trends in advanced medical treatments.

๐‰๐š๐ฉ๐š๐ง: ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Japan continues to lead in medical innovation, with its apheresis market benefiting from strategic consolidations. Companies such as Asahi Kasei Medical Co. Ltd. are expanding their product portfolios through mergers and acquisitions. Japan's aging population and the rising incidence of blood-related disorders have created a strong demand for advanced apheresis solutions. Government support for medical R&D and healthcare advancements further bolsters the market.

๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š: ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

South Korea's focus on advanced healthcare technologies has propelled the growth of its apheresis market. Leading companies like JW Bioscience are investing heavily in R&D to develop cost-effective and innovative apheresis devices. Recent collaborations with global firms have strengthened the country's position as a manufacturing hub for high-quality medical equipment. The increasing prevalence of autoimmune diseases and hematological conditions is driving market demand.

๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž: ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Singapore's strategic focus on healthcare innovation and infrastructure development is driving growth in the apheresis market. Collaborations between local hospitals and global companies such as Fresenius Kabi are enhancing access to advanced apheresis technologies. Singapore's emphasis on precision medicine and clinical trials is fostering the adoption of therapeutic apheresis for treating complex medical conditions, solidifying its position as a key player in the region.

๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ: ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

The United States remains the largest market for apheresis devices, driven by a strong healthcare system, significant R&D investments, and the presence of major industry players like Baxter International Inc.. The country is witnessing increasing adoption of AI-integrated apheresis systems, which enhance procedural efficiency and patient outcomes. Recent mergers, such as Fresenius Kabi's acquisition of a U.S.-based plasma collection firm, highlight consolidation trends shaping the market.

๐„๐ฎ๐ซ๐จ๐ฉ๐ž: ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Europe's apheresis market is evolving rapidly, with a focus on sustainability and innovation. Leading countries like Germany and the UK are investing in eco-friendly apheresis solutions to minimize environmental impact. Companies such as Macopharma are expanding their European operations by launching advanced disposable kits and portable devices. Collaborative efforts between research institutions and medical device manufacturers are driving technological advancements across the region.

๐‚๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ? ๐†๐ซ๐š๐› ๐˜๐จ๐ฎ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐“๐จ๐๐š๐ฒ: https://www.maximizemarketresearch.com/request-sample/12723/

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

by Product

Apheresis Devices
Plasma Separators
Plasma Component Separators
Immunoadsorption Columns
Plasma Perfusion Columns
Hemoperfusion Columns
Apheresis Disposables
Apheresis Market, by Procedure
Automated/Apheresis Blood Collection (Donor Apheresis)
Therapeutic Apheresis

by Disease

Neurological Disorders
Blood Disorders
Cardiovascular Disorders
Renal Disorders
Autoimmune Disorders
Metabolic Disorders
Other Disorders

by Procedure

Therapeutic Plasma Exchange (TPE)
Therapeutic Cytapheresis
Therapeutic Erythrocytapheresis
Therapeutic Plateletpheresis
Leukapheresis
Photopheresis
Extracorporeal Immunoadsorption (ECI)

by Technology

Centrifugation
Intermittent Flow
Continuous Flow
Membrane Separation

by Application

Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukapheresis
Other Applications

๐–๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ž ๐ฅ๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐ž?

1. Haemonetics Corporation
2. Fresenius Medical Care
3. Terumo BCT, Inc.
4. Asahi Kasei Medical Co., Ltd.
5. Kawasumi Laboratories Inc.
6. Cerus Corporation
7. B. Braun Melsungen AG
8. HemaCare Corporation
9. Kaneka Corporation
10. Nikkiso Co., Ltd.

๐Š๐ง๐จ๐ฐ ๐Œ๐จ๐ซ๐ž ๐€๐›๐จ๐ฎ๐ญ ๐“๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: https://www.maximizemarketresearch.com/market-report/apheresis-market-global/12723/

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐Œ๐จ๐ซ๐ž: ๐•๐ข๐ฌ๐ข๐ญ ๐Ž๐ฎ๐ซ ๐–๐ž๐›๐ฌ๐ข๐ญ๐ž ๐Ÿ๐จ๐ซ ๐€๐๐๐ข๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

โ™ฆGlobal Marine Fuel Additives Market https://www.maximizemarketresearch.com/market-report/global-marine-fuel-additives-market/83616/

โ™ฆGlobal Zinc Nickel Alloy Plating Market https://www.maximizemarketresearch.com/market-report/global-zinc-nickel-alloy-plating-market/54372/

โ™ฆGlobal Out of Autoclave Prepregs Market https://www.maximizemarketresearch.com/market-report/global-out-of-autoclave-prepregs-market/78338/

โ™ฆGlobal Automotive Power Glass Sunroof Market https://www.maximizemarketresearch.com/market-report/global-automotive-power-glass-sunroof-market/26393/

โ™ฆGlobal Off Road Fuels Market https://www.maximizemarketresearch.com/market-report/off-road-fuels-market/107489/

โ™ฆGlobal Nano Films Market https://www.maximizemarketresearch.com/market-report/global-nano-films-market/107979/

โ™ฆGlobal Isophorone Diisocyanate Market https://www.maximizemarketresearch.com/market-report/global-isophorone-diisocyanate-market/82716/

MAXIMIZE MARKET RESEARCH PVT. LTD.

โฎ 3rd Floor, Navale IT park Phase 2,

Pune Banglore Highway, Narhe

Pune, Maharashtra 411041, India.

โœ† +91 9607365656

๐Ÿ–‚ sales@maximizemarketresearch.com

๐ŸŒ www.maximizemarketresearch.com

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Apheresis Market on Track to Hit USD 3.50 Billion by 2030, Growing at 7.82 Percentage CAGR here

News-ID: 3823810 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Automotive Telematics Insurance Market to Surge to USD 331.86 Billion by 2032, Fueled by a 15.96% CAGR
Automotive Telematics Insurance Market to Surge to USD 331.86 Billion by 2032, F โ€ฆ
Automotive Telematics Insurance Market size was valued at USD 101.50 Billion in 2024 and the total Automotive Telematics Insurance revenue is expected to grow at a CAGR of 15.96% from 2025 to 2032, reaching nearly USD 331.86 Billion. Automotive Telematics Insurance Market Overview: The Automotive Telematics Insurance Market, often referred to as Usage-Based Insurance (UBI), represents the convergence of telecommunications and informatics within the auto insurance sector. This market revolves around theโ€ฆ
Artificial Intelligence in Agriculture Market to Grow at a Stellar 21.5% CAGR, Targeting US$ 7.88 Bn by 2030
Artificial Intelligence in Agriculture Market to Grow at a Stellar 21.5% CAGR, T โ€ฆ
Artificial Intelligence in Agriculture Market size is expected to grow at 21.5% throughout the forecast period, reaching nearly US$ 7.88 Bn by 2030 Artificial Intelligence in Agriculture Market Overview: The Artificial Intelligence in Agriculture market represents the integration of advanced computational technologies into farming practices to enhance efficiency, productivity, and sustainability. This market encompasses a wide array of solutions, including predictive analytics for crop yield forecasting, computer vision systems for monitoring plantโ€ฆ
Offshore Support Vessels Market to Reach USD 4.16 Billion by 2032, Growing at a 6.5% CAGR
Offshore Support Vessels Market to Reach USD 4.16 Billion by 2032, Growing at a โ€ฆ
Offshore Support Vessels Market size was valued at USD 2510.79 Million in 2024 and the total Offshore Support Vessels revenue is expected to grow at a CAGR of 6.5% from 2025 to 2032, reaching nearly USD 4155.34 Million. Offshore Support Vessels Industry Overview: The offshore support vessels (OSV) industry provides a critical maritime logistical backbone for offshore oil and gas exploration and production activities, as well as a growing role in offshoreโ€ฆ
Commercial Vehicles Market Forecast to Expand from USD 848.63 Billion to USD 1.23 Trillion by 2032
Commercial Vehicles Market Forecast to Expand from USD 848.63 Billion to USD 1.2 โ€ฆ
Commercial Vehicles Market size was valued at USD 848.63 Billion in 2024 and the total Commercial Vehicles revenue is expected to grow at a CAGR of 4.7% from 2025 to 2032, reaching nearly USD 1225.45 Billion. Commercial Vehicles Market Overview: The commercial vehicles market is a vital segment of the global automotive industry, encompassing vehicles designed primarily for transporting goods or passengers for commercial purposes. This broad category includes light commercial vehiclesโ€ฆ

All 5 Releases


More Releases for Apheresis

Apheresis Market Worth $3.9 billion | MarketsandMarketsโ„ข
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarketsโ„ข. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasingโ€ฆ
Apheresis Market Worth $3.9 billion | MarketsandMarkets Trademark
Browse 376 market data Tables and 65 Figures spread through 343 Pages and in-depth TOC on "Apheresis Market by Product (Device (Centrifugation, Membrane Separation) Disposable), Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospital, Blood Collection Center), Region - Global Forecast to 2029 Apheresis Market [https://www.prnewswire.com/news-releases/apheresis-market-worth-3-9-billion--marketsandmarkets-302115226.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at aโ€ฆ
Apheresis Equipment Market - Efficiency, Safety, Success: Apheresis Equipment Sh โ€ฆ
Newark, New Castle, USA: The "Apheresis Equipment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Apheresis Equipment Market: https://www.growthplusreports.com/report/apheresis-equipment-market/8509 This latest report researches the industry structure, sales, revenue,โ€ฆ
Apheresis Equipment Market Report Up to 2031
Visiongain has published a new report on Apheresis Equipment Market Report to 2031. Market is segmented by Product (Disposable apheresis kits, Apheresis machines), by Procedure (Plasmapheresis, Erythrocytaphereswis, Plateletpheresis, Leukapheresis), by Application (Renal diseases, Neurology, Hematology, Others), By Technology (Membrane filtration, Centrifugation). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Apheresis Equipment Companies. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample ofโ€ฆ
Apheresis Market Size to Reach Valuation of $4.20 Billion by 2023 | Automated Ap โ€ฆ
Apheresis system assists in the collection and separation of blood components for donation. In addition, this system can perform removal or exchange of blood components for therapeutic procedures. The American National Red Cross offers various therapeutic apheresis services across the U.S. that include plasmapheresis, photopheresis, LDL apheresis, and stem cell harvest. In addition, the center has employed qualified and specialized staff for apheresis procedures while maintaining the accessibility and availabilityโ€ฆ
Apheresis Market (Therapeutic Apheresis & Donor Apheresis): Trends, Opportunitie โ€ฆ
Global Apheresis Market: Overview Apheresis, also known as pheresis and hemapheresis refers to a procedure that comprises extraction of blood from a donor and separating and preserving its components such as leukocytes, platelets, and plasma. Henceforth, the rest of the components are transfused back into the body of the donor. In this process, several abnormal components are also removed from the blood. The apheresis market is categorized from both the therapeuticโ€ฆ